Efficient synthesis of l-DOPA in Escherichia coli via cofactor and enzyme engineering
Synthetic and Systems Biotechnology · 2026-03 · 11 · 226-236
DOI: 10.1016/j.synbio.2025.09.011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthetic and Systems Biotechnology, 2026-03. Verfasst von Lihao Deng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Science Center for Future Foods, Jiangnan University, 1800 Lihu Road, Wuxi, Jiangsu, 214122, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
The global incidence of Parkinson's disease continues to rise. Levodopa (l-DOPA) is the core therapeutic drug, and efficient and sustainable production methods are needed. However, the complex metabolic pathways and the low catalytic efficiency of enzymes limit biosynthesis of l-DOPA in microorganisms. To address this issue, this study significantly enhanced the production efficiency of l-DOPA through a multi-dimensional, integrated metabolic and enzyme engineering approach. Firstly, the de novo synthesis pathway for l-DOPA was established through optimization of the promoter, ribosome-binding site (RBS), plasmid copy number, and tighly accurately regulating the expression level of key enzymes. Secondly, combined with metabonomic analysis, carbon metabolic flow was diverted, increasing the l-DOPA titer by 36.7 %. Glucose dehydrogenase (BmgdH) and gluconate kinase (gntK) were introduced to construct a cofactor regeneration system, which synergistically enhanced the supply of NADH and FADH2, increasing the l-DOPA conversion rate by 18 %. Next, the substrate tunnel of 4-hydroxyphenylacetic acid-3-monooxygenase subunit B (HpaB) was subjected to rational design, and mutant T292A significantly expanded the substrate channel, improved catalytic efficiency, and decreased l-tyrosine by 87 %. Finally, through the process optimization in a 5 L bioreactor (involving phased pH control and induction timing adjustment) achieved an l-DOPA titer of 60.73 g/L, the highest reported to date for de novo microbial synthesis. This research offers a novel approach for industrial biosynthesis of l-DOPA, and broadens engineering concepts for efficient synthesis of aromatic compounds.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Science Center for Future Foods, Jiangnan University, 1800 Lihu Road, Wuxi, Jiangsu, 214122, China.
- School of Biotechnology and Key Laboratory of Industrial Biotechnology of Ministry of Education, Jiangnan University, Wuxi, 214122, China.
- Jiangsu Province Engineering Research Center of Food Synthetic Biotechnology, Jiangnan University, Wuxi, 214122, China.
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Deng, L., Ping, J., Liu, Z., Linghu, K., Zhang, H., Shan, X., Zeng, W., Li, J., & Zhou, J. (2026). Efficient synthesis of l-DOPA in Escherichia coli via cofactor and enzyme engineering. Synthetic and Systems Biotechnology, 11, 226-236. https://doi.org/10.1016/j.synbio.2025.09.011
Vancouver
Deng L, Ping J, Liu Z, Linghu K, Zhang H, Shan X, et al. Efficient synthesis of l-DOPA in Escherichia coli via cofactor and enzyme engineering. Synthetic and Systems Biotechnology. 2026;11:226-236. doi:10.1016/j.synbio.2025.09.011
BibTeX
@article{Deng2026,
author = {Deng, Lihao and Ping, Jurong and Liu, Zhuoyuan and Linghu, Kai and Zhang, Heng and Shan, Xiaoyu and Zeng, Weizhu and Li, Jianghua and Zhou, Jingwen},
title = {Efficient synthesis of l-DOPA in Escherichia coli via cofactor and enzyme engineering},
journal = {Synthetic and Systems Biotechnology},
year = {2026},
volume = {11},
pages = {226--236},
doi = {10.1016/j.synbio.2025.09.011}
}
EUVIMED